EMERGENT BIOSOLUTIONS INC. Employee Count
The employee counts EMERGENT BIOSOLUTIONS INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 900; Filing 2026-02-27; Lease expense per employee $3,666.67.
- 2024-12-31: Employees (as filed) 900; Filing 2025-03-04; Lease expense per employee $4,444.44.
- 2023-12-31: Employees (as filed) 1,600; Filing 2024-03-08; Lease expense per employee $3,000.00.
- 2022-12-31: Employees (as filed) 2,500; Filing 2023-03-01; Lease expense per employee $2,680.00.
- Available history
- 2008-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 900 | 2026-02-27 | $3,666.67 total lease cost |
| 2024-12-31 | 900 | 2025-03-04 | $4,444.44 total lease cost |
| 2023-12-31 | 1,600 | 2024-03-08 | $3,000.00 total lease cost |
| 2022-12-31 | 2,500 | 2023-03-01 | $2,680.00 total lease cost |
| 2021-12-31 | 2,416 | 2022-02-25 | $2,855.96 total lease cost |
| 2020-12-31 | 2,200 | 2021-02-19 | $2,545.45 total lease cost |
| 2019-12-31 | 1,834 full-time | 2020-02-25 | $1,799.35 total lease cost |
| 2018-12-31 | 1,705 full-time | 2019-02-22 | $1,935.48 rent expense, net |
| 2017-12-31 | 1,256 full-time | 2018-02-23 | $1,273.89 rent expense, net |
| 2016-12-31 | 1,098 full-time | 2017-02-28 | $1,275.05 rent expense, net |
| 2015-12-31 | 1,292 full-time | 2016-02-29 | $1,006.19 rent expense, net |
| 2014-12-31 | 1,280 | 2015-03-06 | $3,593.75 rent expense, net |
| 2013-12-31 | 1,353 | 2014-03-10 | $2,882.48 rent expense, net |
| 2012-12-31 | 877 | 2013-03-08 | $4,104.90 rent expense, net |
| 2011-12-31 | 811 | 2012-03-09 | $4,685.57 rent expense, net |
| 2010-12-31 | 767 | 2011-03-11 | $3,389.83 rent expense, net |
| 2009-12-31 | 652 | 2010-03-05 | |
| 2008-12-31 | 587 | 2009-03-06 |
Headcount breakdown as filed
| Fiscal year end | Employees | Xbrl:BusinessAcquisition | Filing |
|---|---|---|---|
| 2020-12-31 | 2,200 | AdaptPharma: 50 PaxVax: 250 | 2021-02-19 “As of December 31, 2020, we had approximately 2,200 employees.” |
| 2019-12-31 | 1,834 full-time | AdaptPharma: 50 PaxVax: 250 | 2020-02-25 “As of February 14, 2020 , we had 1,834 full-time employees.” |
| 2018-12-31 | 1,705 full-time | AdaptPharma: 50 PaxVax: 250 | 2019-02-22 “As of February 15, 2019, we had 1,705 full-time employees.” |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |